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However, the R² values differedmarkedly with (0.402-0.719) for DT and
(0.747-0.926) for RLM. Noticeably, only for someCT-centers an optimum
threshold setting was observed.
Conclusion(s): The RLM method may show advantages over DT
when structures like Tb.Bone are imaged with limited spatial-resolution
and high image-noise. Further tests need to be performed to verify our
observations and applications on patient data need to be done.
doi:10.1016/j.bonr.2021.100825
P018
Development and external validation of nomograms for
predicting one-year mortality and walking ability of Asian elderly
femoral neck fracture patients after arthroplasty
Guangtao Fu
Guangdong Provincial People's Hospital, Orthopedics, Guangzhou, China
Background/Introduction: Femoral neck fractures are common
in Asian elderly patients and related to high risk of mortality and
walking ability impairment after hip arthroplasty. Simplified
prognosis predicting models are strongly needed for preoperative
clinical decision-making.
Purpose: The purpose of the present study was to create
preoperative patient-specific factors-based nomograms for predicting
mortality and walking ability of Asian elderly femoral neck fracture
patients 1 year after arthroplasty.
Methods: Data of patients N 65 years who underwent primary
unilateral hemiarthroplasty or total hip arthroplasty due to femoral
neck fracture between January 1st, 2012 and June 30th, 2019 in our
center were collected. Candidate variables included demographic data,
comorbidities, and preoperative screening. Main outcomes included
mortality and walking ability in the 1st postoperative year. Patients
were randomly divided into derivation and validation groups.
Nomograms were developed based on multiple logistic regressions of
derivation group via R language. 1000 bootstraps were used for internal
validation. Those models were further tested in the validation group
and the entire data set.
Results: The final analysis was performed on 702 patients after
screening. All-cause mortality one year after arthroplasty of the entire
data set was 23.4%, while the independent walking rate was 74.4%. Age
and preoperative walking ability showed the biggest impact on
mortality and postoperative walking ability, respectively. The bias-
corrected C index for predicting mortality in derivation group and the
entire dataset were 0.717 and 0.712, while they were 0.754 and 0.733
for predicting walking ability impairment.
Conclusion(s):Ourmodels enabled one-yearmortality andwalking
ability predictions in Asian elderly femoral neck fracture patients with
adequate predictive discrimination and calibration. Those models are
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Background/Introduction: Fracture risk is increased in advanced
chronic kidney disease (CKD) patients due to bone abnormalities of
renal osteodystrophy and osteoporosis. Bone biopsy is recommended
before commencement of anti-resorptive therapy to assess bone
turnover, mineralization and volume. MicroCT can assess bone volume
and structure in bone biopsy samples quicker than quantitative
histomorphometry.
Purpose: We aimed to assess if microCT and histomorphometry
methods are interchangeable for trabecular bone volume and structure
assessment of bone biopsy in advanced CKD.
Methods: 40 CKD stages 4-5D patients had trans-iliac bone biopsy
using a 4mm diameter Jamshidi trephine. The bone biopsy core was
scanned at 4.3μm resolution using the Skyscan MicroCT for assessment
of trabecular bone volume/tissue volume (BV/TV) and structure. Then
quantitative histomorphometry was performed using the Bioquant
system. Normal mineralization was defined as osteoid thickness b
20μm. Methods comparison analysis was performed using the Passing-
Bablok regression analysis and the Bland-Altman plot. The study was
approved by the local ethics committee.
Results: All patients had normal mineralization status. The two
methods showed good agreement for trabecular BV/TV assessment
(Figure A). There was a mean of 0.7% (95% CI -0.33 to 1.74)
underestimation of BV/TV by microCT (Figure B). The two methods
also showed good agreement for measurements of trabecular thickness
but not for trabecular number. There was a mean of 0.7% (95% CI -3.79
to 5.20) underestimation of trabecular thickness measurement by
microCT.
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Conclusion(s): MicroCT and histomorphometry are interchangeable
for trabecular bone volume and trabecular thickness assessments in
advanced CKD patients with normal mineralization status.
doi:10.1016/j.bonr.2021.100827
P147
Association between trabecular bone score and sleep patterns:
Findings from a cohort study
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Background/Introduction: Sleep is a vital biological process
involved in the regulation of a variety of metabolic and endocrine
functions, including bone health. Previous studies have reported an
association between sleep (duration and quality) and BMD in
women, but findings remaining conflicting.
Purpose: Investigate the relationship between sleep quality, sleep
duration and trabecular bone score (TBS) in a general population of
elderly adults.
Methods: Study comprised participants from a population-based
cohort of elderly individuals. During the visit at the research center, the
participants underwent DXA assessment from which TBS from the
lumbar spine was estimated. Sleep quality was assessed through the
PSQI (Pittsburgh Sleep Quality Index), a self-rated 19- item
questionnaire, which was filled out with the help of a research nurse.
To test the association between all the sleep parameters and TBSwe ran
linear regression analyses adjusted for age, sex, cohort effect, BMI,
education level, cholesterol levels, diabetes, alcohol use, depression
symptoms, smoking status, history of cardiovascular disease. [FK1] We
tested for interaction between sleep parameters and all covariates, and
thereafter stratified the analysis for presence of depression symptoms.
Results: Among 5,534 individuals, 58.1% were women with a mean
age of 66 years and sleep duration of 6.8 hours. In total 28.5% participants
were classified as poor sleepers. A significant interaction was identified
between depressive symptoms and sleep duration (P-value 0.03) and
sleep quality (P=0.10). Participants defined as poor sleepers without
depression symptoms had lower TBS compared to good sleepers
(beta=-0.03, P-value=0.05) but not observed in those with depressive
symptoms (beta=0.02, P-value=0.6). Longer duration of sleeping was
associated with higher TBS (beta=.042, Pvalue=0.001) but not among
individuals with depressive symptoms (beta=-0.03, Pvalue=0.40.
Conclusion(s): Poor sleep quality and duration are associated with
low TBS only in individuals without depression symptoms.
doi:10.1016/j.bonr.2021.100828
P151
The relationship between bone turnover and flu-like symptoms
after zoledronate following denosumab discontinuation, the
ZOLARMAB study
Anne Sophie Sølling, Torben Harsløf, Bente Langdahl
Aarhus University Hospital, Department of Endocrinology and Internal
Medicine, Aarhus, Denmark
Background/Introduction: In ZOLARMAB, we investigated if
treatment with zoledronate (ZOL) prevents BMD loss after
denosumab (DMAB) discontinuation. 61% of our participants
experienced flu-like symptoms after the first ZOL infusion.
Purpose: To investigate the relationship between bone turnover
and other variables and the acute phase reactions (APR).
Methods: In ZOLARMAB, a randomized, open label, interventional
study with 61 patients discontinuing DMAB after 4.6±1.6 years, we
administrated ZOL 6 months (6M group) or 9 months (9M group)
after the last DMAB or when bone turnover had increased (OBS
group). We re-administrated ZOL if BMD decreased ≥5% or p-CTX
increased ≥1.26 μg/L. Clinicaltrials NCT03087851.
Results: The majority of the patients from the 6M group
experienced APR after ZOL, whereas it was well-balanced in the 9M
and OBS groups (chi-sq, p=0.07) (table). All patients treated with ZOL
based on the p-CTX criteria experienced APR. P-CTX, p-PINP, and p-
BSAP at the time of ZOL treatment were similar between patients
experiencing APR and those that did not, however, in the OBS group p-
CTX was significantly higher among the patients experiencing APR
(pb0.01). Only 14% of men, but 67% women experienced APR (pb0.01).
Age, vitamin D status, duration of DMAB treatment, time since last
DMAB, or previous bisphosphonate treatmentwere not associatedwith
APR. Only 7% experienced APR after the second infusion.
Conclusion(s): High p-CTX levels and female gender might be
associated with a high incidence of acute phase reaction after ZOL
treatment following long-term DMAB.
doi:10.1016/j.bonr.2021.100829
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